Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia

NCT01095562 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Cognitive Deficits in Schizophrenia

Interventions

DRUG: ABT-126
DRUG: Placebo

Sponsor

AbbVie (prior sponsor, Abbott)